In conclusion, we provide evidence that increased expression of EZH2 contributes to the hyperproliferative and apoptosis-resistant phenotype of PAH-PASMCs through both canonical and noncanonical mechanisms. Here, EZH2 is linked to pulmonary arterial hypertension.